The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the body’s natural immune system as well as some therapies. A new study uses novel ...
According to the new study, HIV achieves this with a tissue-specific approach, cloaking itself in a host cell's DNA by ...
The Philadelphia Center was established thirty six years ago because someone or some group had to step up to help people ...
Campaigners in Northern Ireland have called for the introduction of a 'game-changing' drug that will prevent HIV. On Friday ...
The American South has the highest HIV rates in the country, accounting for more than half of new HIV diagnoses nationwide in ...
South Africa has welcomed a U.S. bridging plan worth $115 million to continue funding HIV treatment and prevention programs ...
South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool ...
Even as the medical care needed to treat patients with well-controlled HIV has been significantly streamlined, complex ...
The FDA has approved bioLytical Laboratories' Insti HIV self test. The company touts it as the fastest home-use HIV test available in the U.S., ...
In the wake of massive U.S. cuts to foreign aid, the tiny country of Lesotho in southern Africa faces deep uncertainty and ...
NICE has recommended cabotegravir, the UK’s first long-acting injectable HIV prevention drug, expanding access for people ...
Stigma, late diagnosis, and patchy access keep Europe from its HIV milestones. What will it take to close the gap?